Here, we identified for the first time an association between the variant allele of rs2070096 SNP in the BARD1 gene and a Miller–Payne tumor grade 5, that is, a pCR, not only in the whole patient cohort but also in the subgroup of 16 patients receiving TZ/PZ combo treatment. The gene discussed is BARD1; the disease is neoplasm.